Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Genome Biology
|
February 16, 2008
Temporal regulation of expression of immediate early and second phase transcripts by endothelin-1 in cardiomyocytes
Timothy E Cullingford, Thomais Markou, Stephen J Fuller, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 9, 2020
Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension
Daniel N Meijles, Joshua J Cull, Thomais Markou, et al.
Clinical Science (London, England : 1979)
|
May 8, 2024
Striatin plays a major role in angiotensin II-induced cardiomyocyte and cardiac hypertrophy in mice in vivo
Joshua J Cull, Susanna T E Cooper, Hajed O Alharbi, et al.
European Journal of Heart Failure
|
March 19, 2014
Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology
Guido Tarone, Jean-Luc Balligand, Johann Bauersachs, et al.
Clinical Science (London, England : 1979)
|
July 23, 2021
The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension
Daniel N Meijles, Joshua J Cull, Susanna T E Cooper, et al.
European Journal of Heart Failure
|
February 28, 2014
ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models
Adelino F Leite-Moreira, André P Lourenço, Jean-Luc Balligand, et al.
The Biochemical Journal
|
June 22, 2022
PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responses
Jacqueline J T Marshall, Joshua J Cull, Hajed O Alharbi, et al.
The Biochemical Journal
|
February 11, 2022
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo
Angela Clerk, Daniel N Meijles, Michelle A Hardyman, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Genome Biology
|
February 16, 2008
Temporal regulation of expression of immediate early and second phase transcripts by endothelin-1 in cardiomyocytes
Timothy E Cullingford, Thomais Markou, Stephen J Fuller, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 9, 2020
Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension
Daniel N Meijles, Joshua J Cull, Thomais Markou, et al.
Clinical Science (London, England : 1979)
|
May 8, 2024
Striatin plays a major role in angiotensin II-induced cardiomyocyte and cardiac hypertrophy in mice in vivo
Joshua J Cull, Susanna T E Cooper, Hajed O Alharbi, et al.
European Journal of Heart Failure
|
March 19, 2014
Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology
Guido Tarone, Jean-Luc Balligand, Johann Bauersachs, et al.
Clinical Science (London, England : 1979)
|
July 23, 2021
The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension
Daniel N Meijles, Joshua J Cull, Susanna T E Cooper, et al.
European Journal of Heart Failure
|
February 28, 2014
ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models
Adelino F Leite-Moreira, André P Lourenço, Jean-Luc Balligand, et al.
The Biochemical Journal
|
June 22, 2022
PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responses
Jacqueline J T Marshall, Joshua J Cull, Hajed O Alharbi, et al.
The Biochemical Journal
|
February 11, 2022
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo
Angela Clerk, Daniel N Meijles, Michelle A Hardyman, et al.
Page
of 5